Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=77

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00153101-3954b58c",
        "title": "Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Progression to ESRD",
        "summary": "11 of 2954 against 14 of 2972; risk difference -0.1 points, 95% interval -0.5 to 0.3; NCT00153101, Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.",
        "record": "/library/comparisons/NCT00153101-3954b58c",
        "nct_id": "NCT00153101",
        "kind": "outcome",
        "participants": 5926,
        "risk_difference": {
          "value": -0.0009868681833879924,
          "lower": -0.004567388338020488,
          "upper": 0.002508486016893174
        },
        "group_1": "11 of 2,954",
        "group_2": "14 of 2,972",
        "difference": "-0.1 points",
        "interval": "-0.5 to 0.3",
        "trial_title": "Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo."
      },
      {
        "id": "NCT00153101-42d05fee",
        "title": "Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Hospitalization for Congestive Heart Failure",
        "summary": "134 of 2954 against 129 of 2972; risk difference 0.2 points, 95% interval -0.9 to 1.3; NCT00153101, Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.",
        "record": "/library/comparisons/NCT00153101-42d05fee",
        "nct_id": "NCT00153101",
        "kind": "outcome",
        "participants": 5926,
        "risk_difference": {
          "value": 0.001957106316594237,
          "lower": -0.008578867433040864,
          "upper": 0.01251444490244971
        },
        "group_1": "134 of 2,954",
        "group_2": "129 of 2,972",
        "difference": "0.2 points",
        "interval": "-0.9 to 1.3",
        "trial_title": "Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo."
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=78",
  "request_id": "6sa47n9DpUIeRzaN"
}